Mikkel Bring Christensen

Mikkel Bring Christensen

Clinical Professor

Member of:

  • Clinical Pharmacology


  1. Published

    Glucagon Clearance is Preserved in Type 2 Diabetes

    Grøndahl, M. F. G., Lund, A., Bagger, J. I., Petersen, Tonny Studsgaard, Albrechtsen, Nicolai Jacob Wewer, Holst, Jens Juul, Vilsbøll, Tina, Christensen, Mikkel Bring & Knop, Filip Krag, 2022, In: Diabetes. 71, 1, db210024.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Acute patients discharged without an established diagnosis: risk of mortality and readmission of nonspecific diagnoses compared to disease-specific diagnoses

    Gregersen, R., Villumsen, M., Mottlau, K. H., Maule, C. F., Nygaard, H., Rasmussen, J. H., Christensen, Mikkel Bring & Petersen, Janne, 2024, In: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 32, 1, 11 p., 32.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Effect of a medicines management model on medication-related readmissions in older patients admitted to a medical acute admission unit-A randomized controlled trial

    Graabaek, T., Hedegaard, U., Christensen, Mikkel Bring, Clemmensen, M. H., Knudsen, T. & Aagaard, L., 2019, In: Journal of Evaluation in Clinical Practice. 25, 1, p. 88-96 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Glycemic control and use of glucose-lowering medications in hospital-admitted type 2 diabetes patients over 80 years

    Gotfredsen, D. R., Vinther, S., Petersen, Tonny Studsgaard, Cortes, R., Jensen, T. B., Solem, Espen Victor Jimenez & Christensen, Mikkel Bring, Mar 2020, In: Scientific Reports. 10, 8 p., 4095.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents

    Gasbjerg, Lærke Smidt, Gabe, M. B. N., Hartmann, Bolette, Christensen, Mikkel Bring, Knop, Filip Krag, Holst, Jens Juul & Rosenkilde, Mette, Feb 2018, In: Peptides. 100, p. 173-181

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Exendin(9-39)NH2: Recommendations for clinical use based on a systematic literature review

    Gasbjerg, Lærke Smidt, Bari, E. J., Christensen, Mikkel Bring & Knop, Filip Krag, 2021, In: Diabetes, Obesity and Metabolism. 23, 11, p. 2419-2436

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals

    Gasbjerg, Lærke Smidt, Helsted, M. M., Hartmann, Bolette, wbf943, wbf943, Veedfald, Simon, Stensen, S., Lanng, A. R., Bergmann, N. C., Christensen, Mikkel Bring, Vilsbøll, Tina, Holst, Jens Juul, Rosenkilde, Mette & Knop, Filip Krag, 2020, In: Journal of Clinical Endocrinology and Metabolism. 105, 3, p. e725-e738 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists

    Gasbjerg, Lærke Smidt, Bergmann, N. C., Stensen, S., Christensen, Mikkel Bring, Rosenkilde, Mette, Holst, Jens Juul, Nauck, M. & Knop, Filip Krag, 2020, In: Peptides. 125, 10 p., 170183.

    Research output: Contribution to journalReviewResearchpeer-review

  9. Published
  10. Published

    Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy Individuals

    Gasbjerg, Lærke Smidt, Helsted, M. M., Hartmann, Bolette, Jensen, M. H., Gabe, M. B. N., wbf943, wbf943, Veedfald, Simon, Stensen, S., Lanng, A. R., Bergmann, N. C., Christensen, Mikkel Bring, Vilsbøll, Tina, Holst, Jens Juul, Rosenkilde, Mette & Knop, Filip Krag, 2019, In: Diabetes. 68, 3, p. 906-917

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 96275756